Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes

Abstract Background Patients with systemic lupus erythematosus (SLE) suffered from an increasing risk of cardiovascular diseases. In this multi-center prospective study, we aimed to determine the association between antiphospholipid antibodies (aPLs) and future atherosclerotic cardiovascular disease...

Full description

Saved in:
Bibliographic Details
Main Authors: Can Huang, Yufang Ding, Zhen Chen, Lijun Wu, Wei Wei, Cheng Zhao, Min Yang, Shudian Lin, Qian Wang, Xinping Tian, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Medicine
Subjects:
Systemic lupus erythematosus (SLE)
Antiphospholipid syndrome (APS)
Antiphospholipid antibodies (aPLs)
Atherosclerotic cardiovascular disease (ASCVD)
Aspirin
Online Access:https://doi.org/10.1186/s12916-024-03843-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12916-024-03843-9

Similar Items